Strive Health Raises $550 Million in Series D Funding

Audio By Carbonatix

DENVER--(BUSINESS WIRE)--Sep 9, 2025--

Strive Health, the national leader in value-based kidney care, raised $300 million in a Series D equity round and secured $250 million in debt financing for a combined $550 million capital raise. New Enterprise Associates (NEA) led the equity funding, and additional investments were received from CVS Health Ventures, CapitalG, Echo Health Ventures, Town Hall Ventures and Redpoint, alongside several new institutional investors, including funds and accounts managed by affiliates of BlackRock, Inc. Hercules Capital led the debt financing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909153045/en/

With this $550 million in Series D funding, Strive Health will further scale its business to bring its innovative care model to more patients and providers.

Over 35 million Americans have kidney disease, however 90% of people are unaware of their underlying condition until it progresses to the point when dialysis or a transplant is necessary. Strive’s value-based care approach to kidney disease emphasizes early intervention and preventative care and has demonstrated the ability to deliver meaningful impacts, including a 20% reduction in the total cost of kidney care and a 41% reduction in hospitalizations, while achieving 94% overall patient satisfaction.

With this funding, Strive, and its team of over 700 employees — aka “Strivers” — will strengthen end-to-end strategic partnerships, grow its multi-specialty services and enhance its value-based care model through advanced technology, including AI-driven tools and analytics, as it works to continue delivering tailored kidney care solutions.

“When we founded Strive in 2018, the team set out to transform kidney care,” said Chris Riopelle, Co-Founder and CEO of Strive. “The continued investments from NEA, Strive’s founding capital partner, alongside a syndicate of leading financial institutions combined with valued tech and healthcare strategics, is a clear signal that the Strive team is delivering on that mission. By transforming kidney care, we will ultimately make the healthcare system work better for patients and providers.”

Since its founding, Strive has conducted over 1.3 million patient touchpoints and generated more than $400 million in savings for its health plan and provider partners. Strive currently partners with more than 6,500 providers across all 50 states and manages nearly $5 billion of annual medical spend for over 145,000 people. Over the past few years, Strive launched or expanded relationships with many leading payor, health system and provider partners. Strive’s standard of excellence for its partners and patients is achieved through high-touch, preventative care and AI solutions that generate reductions in total cost of care and improved clinical outcomes.

“We recognize that clinician-led healthcare solutions with meaningful scale are where AI implementations will have the most impact when it comes to improving outcomes for chronic disease management and preventive care — but those companies also happen to be exceedingly rare,” said Mohamad Makhzoumi, Co-CEO of NEA. “NEA remains a proud supporter of Strive’s mission of deploying its innovative care model to slow the progression of kidney disease and we are excited at the potential for Strive’s impact to grow exponentially with this more than half a billion-dollar capital raise.”

ABOUT STRIVE HEALTH

Strive Health is the nation’s leader in value-based kidney care and partner of choice for innovative healthcare payors and providers. Using a unique combination of AI technology, care interventions and seamless integration with local providers, Strive forms an integrated care delivery system that supports the entire patient journey from chronic kidney disease (CKD) to end-stage kidney disease (ESKD). To help patients, Strive partners with commercial and Medicare Advantage payors, Medicare, health systems and physicians through flexible value-based payment arrangements, including risk-based programs. Strive serves over 145,000 people with CKD and ESKD across 50 states and partners with over 6,500 providers. Strive’s case management and population health programs are accredited by the National Committee for Quality Assurance (NCQA), and its technology platform, CareMultiplier™, is certified by HITRUST. To learn more, visit StriveHealth.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250909153045/en/

CONTACT: MEDIA CONTACTS:

Nicole Leatherman

Strive Health Communications

619-917-4807

[email protected] Sands PR

630-248-2765

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA COLORADO

INDUSTRY KEYWORD: HEALTH TECHNOLOGY HOSPITALS HEALTH TECHNOLOGY OTHER HEALTH MANAGED CARE ARTIFICIAL INTELLIGENCE

SOURCE: Strive Health

Copyright Business Wire 2025.

PUB: 09/09/2025 07:02 AM/DISC: 09/09/2025 07:01 AM

http://www.businesswire.com/news/home/20250909153045/en